Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect Of Intravenous Iron In Treating Anemia In Ovarian Cancer Patients In Saskatchewan: A Phase-III, Open-Label, Randomized Trial (IIOVS-01)

NCT06248749 is registered in ClinicalTrials.gov with University of Saskatchewan as lead sponsor.

NCT NCT06248749
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06248749 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect Of Intravenous Iron In Treating Anemia In Ovarian Cancer Patients In Saskatchewan: A Phase-III, Open-Label, Randomized Trial (IIOVS-01)
Lead sponsor
University of Saskatchewan
Phase
Phase 3
Overall status
Not yet recruiting
Start date
February 29, 2024
Completion date
December 1, 2029
Enrollment
200 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

anaemia in ovarian carcinoma